Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004566664 | SCV003278100 | uncertain significance | Familial adenomatous polyposis 1 | 2021-12-30 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 802). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 1120 of the APC protein (p.Gly1120Glu). |
All of Us Research Program, |
RCV003996070 | SCV004831422 | uncertain significance | Classic or attenuated familial adenomatous polyposis | 2023-04-27 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000000839 | SCV000020989 | pathogenic | Gastric cancer | 1992-06-01 | no assertion criteria provided | literature only |